Literature DB >> 25421166

Biomarkers: GDF-15 and risk stratification in atrial fibrillation.

Francisco Marín1, Vanessa Roldán2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25421166     DOI： 10.1038/nrcardio.2014.190

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

Review 1.  Atherothrombosis and atrial fibrillation: Important and often overlapping clinical syndromes.

Authors:  Jeremiah P Depta; Deepak L Bhatt
Journal:  Thromb Haemost       Date:  2010-07-20       Impact factor: 5.249

2.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

3.  High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation.

Authors:  V Roldán; F Marín; J Díaz; P Gallego; E Jover; M Romera; S Manzano-Fernández; T Casas; M Valdés; V Vicente; G Y H Lip
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

4.  Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.

Authors:  Lars Wallentin; Ziad Hijazi; Ulrika Andersson; John H Alexander; Raffaele De Caterina; Michael Hanna; John D Horowitz; Elaine M Hylek; Renato D Lopes; Signild Asberg; Christopher B Granger; Agneta Siegbahn
Journal:  Circulation       Date:  2014-10-07       Impact factor: 29.690

5.  Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients.

Authors:  A M Gallagher; E Setakis; J M Plumb; A Clemens; T-P van Staa
Journal:  Thromb Haemost       Date:  2011-09-08       Impact factor: 5.249

Review 6.  Biomarkers in atrial fibrillation: a clinical review.

Authors:  Ziad Hijazi; Jonas Oldgren; Agneta Siegbahn; Christopher B Granger; Lars Wallentin
Journal:  Eur Heart J       Date:  2013-02-05       Impact factor: 29.983

7.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

Review 8.  Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?

Authors:  Gregory Y H Lip
Journal:  Eur Heart J       Date:  2012-12-20       Impact factor: 29.983

Review 9.  Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.

Authors:  Timothy Watson; Eduard Shantsila; Gregory Y H Lip
Journal:  Lancet       Date:  2009-01-10       Impact factor: 79.321

10.  Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.

Authors:  Shinya Goto; Deepak L Bhatt; Joachim Röther; Mark Alberts; Michael D Hill; Yasuo Ikeda; Shinichiro Uchiyama; Ralph D'Agostino; E Magnus Ohman; Chiau-Suong Liau; Alan T Hirsch; Jean-Louis Mas; Peter W F Wilson; Ramón Corbalán; Franz Aichner; P Gabriel Steg
Journal:  Am Heart J       Date:  2008-09-23       Impact factor: 4.749
  10 in total
  3 in total

1.  CHADS2, CHA2DS2-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation: A nationwide multicenter registry study.

Authors:  Inwu Yu; Tae-Jin Song; Bum Joon Kim; Sung Hyuk Heo; Jin-Man Jung; Kyung-Mi Oh; Chi Kyung Kim; Sungwook Yu; Kwang Yeol Park; Jeong-Min Kim; Jong-Ho Park; Jay Chol Choi; Man-Seok Park; Joon-Tae Kim; Yang-Ha Hwang; Jong-Won Chung; Oh Young Bang; Geong-Moon Kim; Yong-Jae Kim; Seonwoo Kim; Sook Young Woo; Hyun Cho; Woo-Keun Seo
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

2.  Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA2DS2-VASc Scores.

Authors:  José Miguel Rivera-Caravaca; Vanessa Roldán; María Asunción Esteve-Pastor; Mariano Valdés; Vicente Vicente; Gregory Y H Lip; Francisco Marín
Journal:  J Am Heart Assoc       Date:  2017-07-20       Impact factor: 5.501

3.  Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation.

Authors:  Zefeng Wang; Liting Cheng; Junmeng Zhang; Zhuo Liang; Ruiqing Dong; Fei Hang; Xinlu Wang; Ziyu Wang; Yongquan Wu; Jie Du
Journal:  Med Sci Monit       Date:  2020-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.